Rocket Pharmaceuticals, Inc.盘中异动早盘股价大跌5.54%报3.05美元_老虎社区_美港股上老虎

Rocket Pharmaceuticals, Inc.盘中异动早盘股价大跌5.54%报3.05美元

市场透视2025-11-07

北京时间2025年11月07日22时37分，Rocket Pharmaceuticals, Inc.（RCKT.us）股票出现异动，股价急速跳水5.54%。截至发稿，该股报3.05美元/股，成交量19.721万股，换手率0.18%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-68.92百万美元，每股收益-0.62美元，毛利-2.54百万美元，市盈率-1.36倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2581343856?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-07 22:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2581343856","market":"us","top_or_hot":-1,"title":"Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%报3.05美元","media":"市场透视","content":"<div>\n<p>北京时间2025年11月07日22时37分，Rocket Pharmaceuticals, Inc.（RCKT.us）股票出现异动，股价急速跳水5.54%。截至发稿，该股报3.05美元/股，成交量19.721万股，换手率0.18%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-68.92百万美元，每股收益-0.62美元，毛利-2.54百万美元，市盈率-1.36倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rocket Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%报3.05美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRocket Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.54%报3.05美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-07 22:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月07日22时37分，Rocket Pharmaceuticals, Inc.（RCKT.us）股票出现异动，股价急速跳水5.54%。截至发稿，该股报3.05美元/股，成交量19.721万股，换手率0.18%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-68.92百万美元，每股收益-0.62美元，毛利-2.54百万美元，市盈率-1.36倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RCKT","symbol_name":"Rocket Pharmaceuticals, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b","article_id":"2581343856","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722370394f5ea77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2581343856","pubTimestamp":1762526223,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月07日22时37分，Rocket Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.54%。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。消息层面，截至22时37分，《Needham维持Rocket Pharmaceuticals持有评级》资讯为影响Rocket Pharmaceuticals, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RCKT":"Rocket Pharmaceuticals, Inc.","BK4139":"生物科技"},"translate_title":"Rocket Pharmaceuticals, Inc. shares fell 5.54% to $3.05 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RCKT":1.5},"content_text":"北京时间2025年11月07日22时37分，Rocket Pharmaceuticals, Inc.（RCKT.us）股票出现异动，股价急速跳水5.54%。截至发稿，该股报3.05美元/股，成交量19.721万股，换手率0.18%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-68.92百万美元，每股收益-0.62美元，毛利-2.54百万美元，市盈率-1.36倍。机构评级方面，在所有15家参与评级的机构中，47%的券商给予买入建议，47%的券商给予持有建议，6%的券商给予卖出建议。Rocket Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Metavia Inc.、Pharming Group Nv、Nutriband Inc.涨幅较大，Metavia Inc.、Phio Pharmaceuticals Corp.、Azitra Inc较为活跃，换手率分别为109.12%、18.19%、10.62%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Tharimmune, Inc.、Aspire Biopharma Holdings, Inc.，振幅分别为11.69%、10.60%、10.49%。Rocket Pharmaceuticals, Inc.公司简介：Rocket Pharmaceuticals Inc是一家处于临床后期的生物制药公司，专注于为罕见且毁灭性的儿童疾病开发基因疗法。公司的管线产品包括用于治疗 Danaon 病的 RP-A501、用于治疗范可尼贫血的 RP-L102、用于治疗白细胞黏附缺陷的 RP-L201、用于治疗丙酮酸激酶缺乏症的 RP-L301 以及用于治疗婴儿恶性骨硬化症的 RP-L401。公司有一个可报告的业务分部，涉及其基因疗法的研发和商业化准备。消息层面，截至22时37分，《Needham维持Rocket Pharmaceuticals持有评级》资讯为影响Rocket Pharmaceuticals, Inc.的重要信息。该信息摘要如下：Needham分析师Gil Blum维持持有评级。根据TipRanks数据显示，该分析师近一年总胜率为39.8%，总平均回报率为4.7%。分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}